The identification of mesial temporal sclerosis (MTS) on magnetic resonance imaging (MRI) is critical in the evaluation for temporal lobectomy. The purpose of this study was to estimate the prevalence of MTS by MRI in the general population. We reviewed the charts of patients undergoing MRI scans over an 18-month period. In order to be included, patients had to have no history of seizures, and the MRIs had to read as 'normal'. Patients were excluded if there was a history of seizures, mental illness, or alcohol abuse, and if they had a family history of seizures. Ages had to be from 5 to 50 years. All patients had MRI scans performed in three planes on 1.5 T systems. MRI diagnosis of MTS was based on standard visual diagnostic criteria analyzing: (1) hippocampal atrophy and (2) increased hippocampal T2 signal. Out of 375 charts reviewed, 204 met the inclusion criteria. Of the 204, 29 (14%) had abnormal and asymmetric mesial temporal structures consistent with a diagnosis of unilateral MTS. Nineteen (9.3%) had hippocampal atrophy only, two (1%) had T2 signal abnormalities, and eight (4%) met both criteria. There are some 'false positives' and MRI evidence for MTS is only meaningful in the proper clinical context.
INTRODUCTION
Mesial temporal sclerosis (MTS) is the most common cause of temporal lobe epilepsy, and magnetic resonance imaging (MRI) evidence for MTS is critical in the evaluation for temporal lobectomy. First, unilateral hippocampal atrophy predicts a favorable surgical outcome [1] [2] [3] . For example, when there is concordance between ictal electroencephalogram (EEG) and hippocampal atrophy, surgical outcome is excellent in greater than 95% of cases 4, 5 . In fact, the combined MRI and EEG findings have become so important that, in some cases, temporal lobectomy may be considered without ictal recordings [6] [7] [8] [9] .
We 10 recently described a small series of patients with psychogenic non-epileptic seizures whose MRI showed evidence for MTS. Thus, while the sensitivity and usefulness of MRI for MTS is unquestionably high, its specificity (i.e. rate of 'false positives') is unknown. The purpose of this study was to estimate the frequency of such abnormalities in subjects without seizures.
METHODS

Study population
We reviewed the charts of patients undergoing MRI scans over an 18-month period. In order to be included, patients had to meet the following criteria:
• Ages from 5 to 50 years.
• No history of seizures, psychiatric disease, and alcohol abuse. • No family history of seizures.
MRI had to meet the following criteria:
• Performed for vague non-specific symptoms (headaches, dizziness) or screening for metastases or cerebral aneurysms.
• Read as 'normal' during the routine (and official) interpretation, not specifically examining mesial temporal structures.
MRI technique
All patients had MRI scans performed in three planes on 1.5 T systems, with slice thickness of 4 mm, and all scans afforded adequate visualization of the mesial temporal lobe structures.
MRI review
These MRI scans were then examined by a neuroradiologist (FRM, senior member of the ASNR and Certificate of added qualification). Estimates of hippocampal volume were made on both T1 and T2-weighted images in all patients. MRI diagnosis of MTS was based on standard visual diagnostic criteria [1] [2] [3] [4] [5] analyzing: (1) hippocampal atrophy and (2) increased hippocampal T2 signal.
RESULTS
Results are summarized in Fig. 1 . We reviewed 375 charts, and 204 met the inclusion criteria. Of the 204, 29 (14%) had abnormal and asymmetric mesial temporal structures consistent with a diagnosis of unilateral MTS. Nineteen (9.3%) had hippocampal atrophy only, two (1%) had T2 signal abnormalities, and eight (4%) met both criteria. In addition, another 32 (15.7%) patients were thought to have symmetric mesial structures abnormalities. An example of normal and hippocampal atrophy (right side) are shown (see Figs. 2 and 3 ).
DISCUSSION
In this series, we found that 14% of patients undergoing MRI for 'non-seizure reasons', and whose MRI failed to disclose gross abnormalities, had asymmetric abnormalities of the mesial temporal structures that could suggest a diagnosis of MTS. In fact, 4% of the patients had reasonably definite evidence for MTS, meeting both criteria. That MRI evidence that MTS can be present in patients without seizures is not all that surprising, since even in the best series 10-20% of patients with clear hippocampal atrophy can fail a temporal lobectomy, possibly indicating that the MRI abnormality was not the source of the seizures. Our rate of 'false positive' is consistent with the specificity of 86% reported by others 11 . Hippocampal atrophy has also been reported in children with benign childhood epilepsy with centrotemporal spikes 12 , where it is likely to represent an incidental finding. Thus, while MRI evidence of MTS is critical in the presurgical evaluation, it should not be used to make a diagnosis of epilepsy. Indeed, MRI evidence of MTS only has meaning in the proper (electro-clinical) context 10, 13 . This pitfall is in many ways comparable to what happened with the diagnosis of multiple sclerosis (MS) in the early days of MRI. Because of the extreme sensitivity of MRI, many patients were given presumptive diagnoses of MS based on MRI findings, until it became apparent that these findings were nonspecific and that many subjects without symptoms had MRI 'consistent with MS'. Another analogous example is the specificity of MRI for lumbosacral spondylosis 14, 15 . To some degree a comparable situation exists for most imaging or laboratory tests. As with the MRI of MS, the MRI of MTS is only of value when interpreted in the proper clinical context.
The prevalence of such mesial temporal abnormalities in subjects without seizures has not been extensively studied. One series 16 found such 'false positives' in only two (1%) of 207 patients who had an MRI for hearing loss, but these were performed using only T2-weighted fast spin-echo imaging. Because of its high sensitivity, MRI often reveals other incidental abnormalities even in healthy volunteers, including white matter lesions, old lacunar infarcts, arachnoid cysts, and cavernous angiomas 17 . Compared to other abnormalities, MTS is an important one because seizures are frequent (affecting at least 1% of the population), and MTS in the presence of seizures may indicate that seizures are likely to be intractable 18 and could be treated with surgery.
Several potential shortcomings of our study warrant discussion. First, hippocampal atrophy has been reported in dementia with Lewy body 19 , alcoholism 20 and schizophrenia 21 . For that reason, we were careful to exclude older patients, and patients with a history of dementia, psychiatric disease, or alcohol abuse. However, we cannot absolutely exclude that our patients with MRI evidence of MTS later developed any of these conditions, or even temporal lobe seizures. Second, our sample did not truly represent a 'normal' population. Nevertheless, we feel that it was an adequate approximation, since the symptoms or reasons for the MRIs were clearly irrelevant to hippocampal atrophy. Third, using different imaging protocols may produce different results than the routine technique used here. For example, quantitative analysis or 'volumetry' 4 and FLAIR images 22 may improve sensitivity of MRI for the detection of MTS. We also recognize that there is an element of subjectivity when visually analyzing MRI for the possibility of MTS. For that reason, we used various criteria with two degrees of 'evidence' (one criterion or two criteria). Thus, our findings are still useful since we are at least getting a minimalistic (conservative) estimate (underestimate) of the 'false positive' MRI. Our findings would indicate that at least 4% of the population may have MRI evidence for unilateral hippocampal atrophy, documenting the possibility of 'false positives'. Ideally, our finding should be confirmed by a prospective study in healthy individuals.
